Delivery Order SPE2DB24D8003-SPE2DB25FJTYP
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This federal contract award, valued at $7,561.86, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order without a set-aside designation, with a firm fixed-price pricing type and an ultimate completion date of December 17, 2024. The contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7B3Y, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $17,482.96, is for the delivery of Concerta ER 18 mg tablets in 100-count bottles. This is a firm fixed-price delivery order contract with an ultimate completion date of October 12, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a...
This federal contract award, valued at $5,353.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJTSA) under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $23,774.87 Firm Fixed Price delivery order contract is for the delivery of 4562940892 CONCERTA ER 27 MG TABLET 100S. The award is not associated with a set-aside program and has an ultimate completion date of November 30, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 single-award Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,060.46, is for the delivery of Concerta ER 27 mg tablets in quantities of 100. The contract has an ultimate completion date of January 3, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, and holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
This federal contract award, valued at $5,702.38, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. This award is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...